HEADER STRUCTURAL PROTEIN 30-JUN-12 2LVC TITLE SOLUTION NMR STRUCTURE OF IG LIKE DOMAIN (805-892) OF OBSCURIN-LIKE TITLE 2 PROTEIN 1 FROM HOMO SAPIENS, NORTHEAST STRUCTURAL GENOMICS CONSORTIUM TITLE 3 (NESG) TARGET HR8578K COMPND MOL_ID: 1; COMPND 2 MOLECULE: OBSCURIN-LIKE PROTEIN 1; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: IG-LIKE 6 DOMAIN RESIDUES 805-892; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: KIAA0657, OBSL1; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21(DE3)PMGK; SOURCE 9 EXPRESSION_SYSTEM_VECTOR: PET15AVI6HT_NESG KEYWDS STRUCTURAL GENOMICS, NORTHEAST STRUCTURAL GENOMICS CONSORTIUM (NESG), KEYWDS 2 PSI-BIOLOGY, PROTEIN STRUCTURE INITIATIVE, STRUCTURAL PROTEIN EXPDTA SOLUTION NMR NUMMDL 20 AUTHOR S.PULAVARTI,A.ELETSKY,D.K.SUKUMARAN,D.LEE,E.KOHAN,H.JANJUA,R.XIAO, AUTHOR 2 T.B.ACTON,J.K.EVERETT,K.PEDERSON,J.PRESTEGARD,G.T.MONTELIONE, AUTHOR 3 T.SZYPERSKI,NORTHEAST STRUCTURAL GENOMICS CONSORTIUM (NESG) REVDAT 3 15-MAY-24 2LVC 1 REMARK REVDAT 2 14-JUN-23 2LVC 1 REMARK SEQADV REVDAT 1 29-AUG-12 2LVC 0 JRNL AUTH S.PULAVARTI,A.ELETSKY,D.K.SUKUMARAN,D.LEE,E.KOHAN,H.JANJUA, JRNL AUTH 2 R.XIAO,T.B.ACTON,J.K.EVERETT,K.PEDERSON,J.PRESTEGARD, JRNL AUTH 3 G.T.MONTELIONE,T.SZYPERSKI JRNL TITL SOLUTION NMR STRUCTURE OF IG LIKE DOMAIN (805-892) OF JRNL TITL 2 OBSCURIN-LIKE PROTEIN 1 FROM HOMO SAPIENS, NORTHEAST JRNL TITL 3 STRUCTURAL GENOMICS CONSORTIUM (NESG) TARGET HR8578K (CASP JRNL TITL 4 TARGET) JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS, CYANA 3.0, AUTOSTRUCTURE 2.1 REMARK 3 AUTHORS : BRUNGER, ADAMS, CLORE, GROS, NILGES AND READ REMARK 3 (CNS), GUNTERT, MUMENTHALER AND WUTHRICH (CYANA), REMARK 3 HUANG, TEJERO, POWERS AND MONTELIONE REMARK 3 (AUTOSTRUCTURE) REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: STRUCTURE DETERMINATION WAS PERFORMED REMARK 3 BY CYANA AND AUTOSTRUCTURE IN PARALLEL USING NOE-BASED REMARK 3 CONSTRAINTS AND PHI AND PSI DIHEDRAL ANGLE CONSTRAINTS. REMARK 3 CONSENSUS PEAK ASSIGNMENTS GENERATED FROM THESE PARALLEL RUNS REMARK 3 WERE SELECTED AND USED FOR FURTHER REFINEMENT WITH CYANA, THE REMARK 3 RDC CONSTRAINTS WERE ADDED AT LATER STAGES. A TOTAL OF 20 REMARK 3 CONFORMERS OUT OF 100 CONFORMERS WITH THE LOWEST TARGET FUNCTION REMARK 3 WERE SELECTED FOR REFINEMENT WITH CNS USING CNS WATER BATH REMARK 3 REFINEMENT REMARK 4 REMARK 4 2LVC COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 03-JUL-12. REMARK 100 THE DEPOSITION ID IS D_1000102879. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 298 REMARK 210 PH : 6.5 REMARK 210 IONIC STRENGTH : NULL REMARK 210 PRESSURE : AMBIENT REMARK 210 SAMPLE CONTENTS : 1.0 MM [U-100% 13C; U-100% 15N] REMARK 210 HR8578K.009, 0.02 % NAN3, 10 MM REMARK 210 DTT, 5 MM CACL2, 100 MM NACL, 1 REMARK 210 X PROTEINASE INHIBITORS, 20 MM REMARK 210 MES PH 6.5, 10 % D2O, 50 UM DSS, REMARK 210 90% H2O/10% D2O; 1.0 MM [U-5% REMARK 210 13C; U-100% 15N] HR8578K.010, REMARK 210 0.02 % NAN3, 10 MM DTT, 5 MM REMARK 210 CACL2, 100 MM NACL, 1 X REMARK 210 PROTEINASE INHIBITORS, 20 MM MES REMARK 210 PH 6.5, 10 % D2O, 50 UM DSS, 90% REMARK 210 H2O/10% D2O; 0.6 MM [U-5% 13C; U- REMARK 210 100% 15N] HR8578K.010, 0.02 % REMARK 210 NAN3, 10 MM DTT, 5 MM CACL2, 100 REMARK 210 MM NACL, 1 X PROTEINASE REMARK 210 INHIBITORS, 20 MM MES PH 6.5, 10 REMARK 210 % D2O, 50 UM DSS, 12.5 MG/ML PF1 REMARK 210 PHAGE, 80% H2O/20% D2O; 0.6 MM REMARK 210 [U-5% 13C; U-100% 15N] REMARK 210 HR8578K.010, 0.02 % NAN3, 10 MM REMARK 210 DTT, 5 MM CACL2, 100 MM NACL, 1 REMARK 210 X PROTEINASE INHIBITORS, 20 MM REMARK 210 MES PH 6.5, 10 % D2O, 50 UM DSS, REMARK 210 4 % PEG, 80% H2O/20% D2O REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : 2D 1H-15N HSQC; 2D 1H-13C (CT-27 REMARK 210 MS) HSQC; 3D HNCO; 3D CBCA(CO)NH; REMARK 210 3D HNCACB; 3D HN(CA)CO; 3D REMARK 210 SIMUTANEOUS 13C-AROMATIC,13C- REMARK 210 ALIPHATIC,15N EDITED 1H-1H NOESY; REMARK 210 2D 1H-13C (CT-28 MS) HSQC; 2D REMARK 210 1H-13C (CT-56 MS) HSQC; 2D 1H- REMARK 210 13C (CT-42 MS) HSQC; 3D C(CO)NH; REMARK 210 3D HCCH-TOCSY; 3D HBHA(CO)NH; 3D REMARK 210 H(CCO)NH; 3D HCCH-COSY REMARK 210 (ALIPHATIC); 3D HCCH-COSY REMARK 210 (AROMATIC); 2D 1H-15N HSQC J-MOD REMARK 210 SPECTROMETER FIELD STRENGTH : 600 MHZ; 750 MHZ REMARK 210 SPECTROMETER MODEL : INOVA REMARK 210 SPECTROMETER MANUFACTURER : VARIAN REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : CNS, CYANA 3.0, AUTOSTRUCTURE REMARK 210 2.1, AUTOASSIGN 2.1, CARA 1.8.4, REMARK 210 XEASY, CSI, VNMRJ, PROSA, TALOS+, REMARK 210 PALES, PSVS REMARK 210 METHOD USED : SIMULATED ANNEALING REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 100 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 20 REMARK 210 CONFORMERS, SELECTION CRITERIA : STRUCTURES WITH THE LOWEST REMARK 210 ENERGY REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 1 REMARK 210 REMARK 210 REMARK: NULL REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 465 SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 MODELS 1-20 REMARK 465 RES C SSSEQI REMARK 465 SER A 0 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 1 PRO A 3 -86.03 -55.42 REMARK 500 1 VAL A 4 139.56 -176.96 REMARK 500 1 ARG A 10 64.33 -106.10 REMARK 500 1 GLU A 44 124.80 72.44 REMARK 500 2 PRO A 3 -165.51 -78.07 REMARK 500 2 GLU A 44 125.01 70.33 REMARK 500 2 GLU A 47 94.18 -68.21 REMARK 500 2 VAL A 51 98.81 -69.01 REMARK 500 3 MET A 2 94.13 60.98 REMARK 500 3 THR A 19 9.88 -62.67 REMARK 500 3 SER A 20 16.79 -141.56 REMARK 500 3 LYS A 40 -91.54 -133.79 REMARK 500 3 GLU A 47 95.58 47.65 REMARK 500 3 ASP A 49 -70.57 53.54 REMARK 500 4 LYS A 40 -70.33 -161.98 REMARK 500 4 ASP A 49 -63.95 -160.30 REMARK 500 4 GLN A 68 139.07 67.23 REMARK 500 4 PRO A 69 48.45 -74.96 REMARK 500 4 SER A 70 -52.76 -167.23 REMARK 500 5 ASP A 41 88.47 -176.30 REMARK 500 5 GLU A 56 106.21 -160.21 REMARK 500 6 PRO A 3 99.86 -55.92 REMARK 500 6 ARG A 10 42.65 -83.74 REMARK 500 6 ASP A 41 -72.26 66.32 REMARK 500 6 ASP A 49 -71.05 -178.68 REMARK 500 6 PRO A 65 -70.36 -62.77 REMARK 500 6 GLN A 68 174.30 63.09 REMARK 500 7 ARG A 10 -69.66 73.87 REMARK 500 7 ASP A 41 108.88 -59.34 REMARK 500 7 SER A 48 -166.25 -161.31 REMARK 500 7 GLU A 56 82.97 -161.73 REMARK 500 7 PRO A 65 -71.73 -54.01 REMARK 500 7 THR A 67 100.00 -65.28 REMARK 500 7 ALA A 79 -70.08 -107.70 REMARK 500 8 THR A 19 -74.74 56.62 REMARK 500 8 SER A 48 -156.15 -146.24 REMARK 500 8 ASP A 49 101.32 -54.81 REMARK 500 9 PRO A 35 -151.81 -92.21 REMARK 500 9 GLU A 44 122.52 75.73 REMARK 500 9 GLU A 46 46.19 -102.47 REMARK 500 9 GLN A 68 -161.95 56.20 REMARK 500 10 ASP A 49 -71.19 -160.55 REMARK 500 11 GLN A 43 45.75 -84.85 REMARK 500 11 GLU A 44 -167.12 59.28 REMARK 500 11 GLU A 46 154.24 64.72 REMARK 500 11 GLU A 47 44.31 -99.12 REMARK 500 11 PHE A 50 -3.65 73.02 REMARK 500 11 GLN A 68 163.32 67.80 REMARK 500 12 ASP A 41 94.77 -48.72 REMARK 500 12 GLU A 46 91.97 62.08 REMARK 500 REMARK 500 THIS ENTRY HAS 93 RAMACHANDRAN OUTLIERS. REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 18563 RELATED DB: BMRB REMARK 900 RELATED ID: NESG-HR8578K RELATED DB: TARGETTRACK DBREF 2LVC A 3 90 UNP O75147 OBSL1_HUMAN 805 892 SEQADV 2LVC SER A 0 UNP O75147 EXPRESSION TAG SEQADV 2LVC HIS A 1 UNP O75147 EXPRESSION TAG SEQADV 2LVC MET A 2 UNP O75147 EXPRESSION TAG SEQRES 1 A 91 SER HIS MET PRO VAL HIS ILE VAL ASP PRO ARG GLU HIS SEQRES 2 A 91 VAL PHE VAL HIS ALA ILE THR SER GLU CYS VAL MET LEU SEQRES 3 A 91 ALA CYS GLU VAL ASP ARG GLU ASP ALA PRO VAL ARG TRP SEQRES 4 A 91 TYR LYS ASP GLY GLN GLU VAL GLU GLU SER ASP PHE VAL SEQRES 5 A 91 VAL LEU GLU ASN GLU GLY PRO HIS ARG ARG LEU VAL LEU SEQRES 6 A 91 PRO ALA THR GLN PRO SER ASP GLY GLY GLU PHE GLN CYS SEQRES 7 A 91 VAL ALA GLY ASP GLU CYS ALA TYR PHE THR VAL THR ILE HELIX 1 1 GLN A 68 GLY A 72 5 5 SHEET 1 A 4 VAL A 13 HIS A 16 0 SHEET 2 A 4 CYS A 83 THR A 89 1 O THR A 89 N VAL A 15 SHEET 3 A 4 GLU A 74 VAL A 78 -1 N PHE A 75 O PHE A 86 SHEET 4 A 4 ARG A 37 LYS A 40 -1 N ARG A 37 O VAL A 78 SHEET 1 B 3 VAL A 23 GLU A 28 0 SHEET 2 B 3 HIS A 59 LEU A 64 -1 O ARG A 60 N CYS A 27 SHEET 3 B 3 VAL A 52 GLU A 56 -1 N GLU A 56 O HIS A 59 CISPEP 1 ASP A 8 PRO A 9 1 -5.04 CISPEP 2 ASP A 8 PRO A 9 2 -1.96 CISPEP 3 ASP A 8 PRO A 9 3 -1.39 CISPEP 4 ASP A 8 PRO A 9 4 -4.04 CISPEP 5 ASP A 8 PRO A 9 5 -5.25 CISPEP 6 ASP A 8 PRO A 9 6 -0.82 CISPEP 7 ASP A 8 PRO A 9 7 -6.50 CISPEP 8 ASP A 8 PRO A 9 8 -1.98 CISPEP 9 ASP A 8 PRO A 9 9 -3.77 CISPEP 10 ASP A 8 PRO A 9 10 -6.74 CISPEP 11 ASP A 8 PRO A 9 11 -4.90 CISPEP 12 ASP A 8 PRO A 9 12 -5.09 CISPEP 13 ASP A 8 PRO A 9 13 -10.18 CISPEP 14 ASP A 8 PRO A 9 14 1.08 CISPEP 15 ASP A 8 PRO A 9 15 3.09 CISPEP 16 ASP A 8 PRO A 9 16 -5.11 CISPEP 17 ASP A 8 PRO A 9 17 -1.84 CISPEP 18 ASP A 8 PRO A 9 18 -1.29 CISPEP 19 ASP A 8 PRO A 9 19 -1.49 CISPEP 20 ASP A 8 PRO A 9 20 -7.73 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 MODEL 1